Further, we investigated whether fluoxetine, the most widely prescribed antidepressant in clinical practice, could improve the depression-like behaviors in Fto cKO mice and whether the ADRB2-c-MYC-SIRT1 signaling pathway was involved in the actions of fluoxetine. The gene discussed is SIRT1; the disease is depressive disorder.